Leda
Negotiable Min Order Quantity Unit
- Required Quantity
-
- Place of Origin
- South Korea
- Payment Terms
- Negotiable
- Production method
- Negotiable
- Shipping / Lead Time
- Negotiable / Negotiable
- Keyword
- facial beauty care, facial mask, facial ampoule, leda
- Category
- Skin Care Set
DONGWHA PHARM CO LTD
- Country / Year Established
- South Korea / 1897
- Business type
- Manufacturer
- Verified Certificate
-
16
Product name | Leda | Certification | - |
---|---|---|---|
Category | Skin Care Set | Ingredients | - |
Keyword | facial beauty care , facial mask , facial ampoule , leda | Unit Size | - |
Brand name | - | Unit Weigh | - |
origin | South Korea | Stock | - |
Supply type | - | HS code | - |
Product Information
http://www.dwpharm-dc.com/leda_list
DongWha Pharmaceuticals unveiled ‘LEDA®,’ a cosmetics brand for hospitals and clinics. ‘LEDA®’ contains human cord blood cell conditioned media, and was developed to care for weakened skin after laser treatment.
Facial skin tends to be very dry and sensitive after laser treatment, and requires special care.
‘LEDA®’s human cord blood cell conditioned media includes anti-oxidative factors, growth factors related to skin protection, and epidermal growth factors. It also contains adenosine to reduce wrinkles, peptides to strengthen skin barriers, and hyaluronic acid to moisturize sensitive skin.
‘LEDA®’ is a cosmetics brand for hospitals and clinics. It aims to achieve mythological beauty, as its brand name came from a story of Zeus, the king of the gods who admired LEDA, the queen of Sparta, and seduced her in the guise of a swan. LEDA® stem source serum (10 ml) and cream (50 ml) are available at hospitals and clinics.
(For more information: Dong Wha Customer Center 080-023-1897)
B2B Trade
Price (FOB) | Negotiable | transportation | - |
---|---|---|---|
MOQ | Negotiable | Leadtime | Negotiable |
Payment Options | Negotiable | Shipping time | Negotiable |
- President
- KI HWAN PARK
- Address
- 6-8F, 24, NAMDAEMUN-RO, 9-GIL, JUNG-GU, SEOUL, 04522, KOREA, Jung-gu, Seoul, Korea
- Product Category
- Pharmaceuticals
- Year Established
- 1897
- No. of Total Employees
- 501-1000
- Company introduction
-
In 1897, a small company named ‘Dong WhaYakbang’ was established in Jeong-dong, where Western culture was introduced ata turbulent time in Korean history. A royal court officer of the ChosunDynasty, Byung Ho Min, created Korea’s first Western-style medicine byintegrating the advantages of Western medical techniques into the royal court’ssecret recipe.
This digestive medicine, known as WhalMyung Su, meaning ‘life-saving water’, soothed people’s pain in those turbulenttimes and became a reliable “comrade” for independence fighters. Since itscreation, Whal Myung Su has been loved as the nation’s favorite digestivemedicine for 117 years amid ever-changing social circumstances and greatturmoil due to the company’s conviction that ‘We will save people with goodmedicine’.
We run our company according to the beliefthat making medicine is not a simple business activity, but a sacred andbeautiful duty that brings happiness to humans.
Honorable titles bestowed by the people,such as ‘The First’ or ‘The Best’, are earned through such a conviction.
Now, Dong Wha Pharm, as Korea’s first andoldest pharmaceutical company, is ready to launch a new era of 100 years basedon such pride. We will abide by our founder’s first intent, ‘Do not make anymedicines but good medicines’. We will be reborn as a self-regulating, adaptivecompany through change and innovation. Based on our accumulated technology and experience,we will make new products of the highest quality. With our happiness managementphilosophy, we will make Dong Wha as the company where each employee can havebig dreams.
Lastly, we will contribute to human healthand happiness. Please join us in exploring this new era.
* Dong Wha Pharm Research Institute, the Backbone of New MedicineDevelopment
Since its establishment in 1973, Dong WhaPharm Research Institute has developed numerous superior medicines and the mostadvanced drugs. It is now set to become a global hub for new drug development.
In order to create a new world-class drug,the research center will focus on R&D (Research and Development), andexpand its assistance and investment on fostering professional human resources.
* World-class advanced production facilities, Chungju cGMP plant
In 2009, at the Chungju Industrial Complex,Dong Wha Pharm completed the construction of state-of-the-art production facilities,comprising of four stories aboveground and one underground level with a totalof 82,500m2 including total floor space of 52,644m2.
The Chungju Plant is equipped withequipment and facilities that satisfy Current Good Manufacturing Practice(cGMP) Regulations of US F. D. A. In addition, the plant has been evaluated asa world-class pharmaceutical company by the installment of high-tech plantautomation system.
Dong Wha Pharm pursues 100% zero defectswith its independent quality assurance system, which encompasses the procurementof raw materials, production processes, packaging and shipment.
- Main Markets
-
Germany
Indonesia
Japan
Mexico
Portugal
Spain
U.S.A
Viet Nam
- Factory Information
-
DONG WHA CHUNGJU PLANT
- Main Product